Abstract: A medical implant and/or device, which includes a biodegradable and cytocompatible magnesium-zinc-strontium alloy is disclosed. The implant and/or device can include a biodegradable and cytocompatible magnesium-zinc-strontium (Mg—Zn—Sr) alloy having a weight percent composition of Zn and Sr as follows: 0.01?Zn?6 wt %, 0.01?Sr?3 wt %. A method for manufacturing an implant in the form of a biodegradable and cytocompatible magnesium-zinc-strontium alloy is disclosed, which includes melting the biodegradable and cytocompatible magnesium-zinc-strontium alloy in an inert environment and molding the biodegradable magnesium-zinc-strontium alloy in a semi-solid state.
Type:
Application
Filed:
August 26, 2013
Publication date:
April 3, 2014
Applicant:
The Regents of the University of California
Abstract: The present invention relates to polyvinyl sulfonic acid comprising a vinyl sulfonic acid unit represented by a specific general formula (1), wherein the molar amount of sulfonic acid groups derived from vinyl sulfonic acid monomers with respect to the molar amount of total monomer units is 50.0 to 98.0 mol %, and the polyvinyl sulfonic acid has an absorbance of 0.1 or greater (aqueous solution: 0.2 mass %, cell length: 10 mm) in a wavelength range of 255 to 800 nm.
Type:
Application
Filed:
April 26, 2012
Publication date:
April 3, 2014
Applicants:
UNIVERSITY OF YAMANASHI, ASAHI KASEI FINECHEM CO., LTD.
Abstract: Aspects of the present disclosure are directed to apparatuses and methods involving nanowires having junctions therebetween. As consistent with one or more embodiments, an apparatus includes first and second sets of nanowires, in which the second set overlaps the first set. The apparatus further includes a plurality of nanowire joining recrystallization junctions, each junction including material from a nanowire of the first set that is recrystallized into an overlapping nanowire of the second set.
Type:
Application
Filed:
October 1, 2013
Publication date:
April 3, 2014
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
Erik C. Garnett, Mark L. Brongersma, Yi Cui, Michael D. McGehee, Mark Greyson Christoforo, Wenshan Cai
Abstract: The present invention is directed to composite metal foams comprising hollow metallic spheres and a solid metal matrix. The composite metal foams show high strength, particularly in comparison to previous metal foams, while maintaining a favorable strength to density ratio. The composite metal foams can be prepared by various techniques, such as powder metallurgy and casting.
Abstract: The present disclosure provides a method for making touch panel. A carbon nanotube structure is formed on a substrate. The carbon nanotube structure includes a number of carbon nanotubes. The number of carbon nanotubes are arranged isotropically, arranged along a same direction, or arranged along different directions. Two electrodes are electrically connected with the carbon nanotube structure. Furthermore, a primary alignment direction of the number of carbon nanotubes and a surface of the carbon nanotube structure in contact with the substrate is greater than 0° and smaller than 15°.
Type:
Application
Filed:
December 5, 2013
Publication date:
April 3, 2014
Applicants:
HON HAI PRECISION INDUSTRY CO., LTD., Tsinghua University
Inventors:
CHANG-HONG LIU, KAI-LI JIANG, LIANG LIU, SHOU-SHAN FAN
Abstract: An apparatus and method for detecting an analyte are described. The apparatus includes at least one microchannel adapted for an analyte to adhere to an interior surface thereof, a mixing element positioned within at least a portion of the at least one microchannel, a light source for energizing quantum dots conjugated with the analyte within the at least one microchannel, and a detection system for detecting and quantifying fluorescent energy emitted by the quantum dots in one or more predetermined wavelength ranges, wherein each wavelength range being correlated to one and only one type of analyte.
Type:
Application
Filed:
October 1, 2013
Publication date:
April 3, 2014
Applicant:
Drexel University
Inventors:
Elisabeth Papazoglou, Hongseok Noh, Chengjie Yu, Peter M. Clark
Abstract: An HLA-binding peptide binding to a HLA-A type molecule, the HLA-binding peptide includes at least one type of amino acid sequence selected from the group consisting of SEQ ID NOS: 1 to 80, and consists of not less than 8 and not more than 11 amino acid residues. All of these amino acid sequences herein mentioned are the predicted amino acid sequences binding to a human HLA-A type molecule with the prediction program using the certain active learnig method.
Abstract: A computer implemented method for sensing occupancy of a workspace includes creating a difference image that represents luminance differences of pixels in past and current images of the workspace resulting from motion in the workspace, determining motion occurring in regions of the workspace based on the difference image, and altering a workspace environment based at least in part on the determined motion. The method also includes determining which pixels in the difference image represent persistent motion that can be ignored and determining which pixels representing motion in the difference image are invalid because the pixels are isolated from other pixels representing motion.
Type:
Application
Filed:
June 8, 2012
Publication date:
April 3, 2014
Applicant:
UTAH STATE UNIVERSITY RESEARCH FOUNDATION
Inventors:
Aravind Dasu, Dean Mathias, Chenguang Liu, Randy Christensen, Bruce Christensen
Abstract: Techniques for presenting content provided by a mobile device on a second communication device are presented. A content enhancer component (CEC) connects via a wired or wireless communication connection to the second communication device to communicate content to the second communication device, which has a larger display than or superior audio to the mobile device. The CEC captures content and interaction between the user and mobile device in a capture region of the CEC. The CEC reconstructs the content and the user-related interaction for presentation on the second communication device. The second communication device can have a 2-D or 3-D display. If a 3-D display, the CEC can convert captured video content into a 3-D format to provide 3-D perception when content is displayed on the second communication device. The captured audio signal can be processed to provide an enhanced stereo or 3-D sound effect.
Abstract: A set of biomarkers have been identified that allows one to predict subjects who will respond to an exercise regime in term of cardiorespiratory fitness as assessed by maximal oxygen uptake. These predictions may be used, for example, to predict risk of cardiovascular disease, to design a more effective program for cardiac rehabilitation, to predict capacity for athletic performance or physically demanding occupation, and to predict ability to maintain functional capacity with aging using exercise.
Type:
Application
Filed:
September 6, 2013
Publication date:
April 3, 2014
Applicants:
Medical Prognosis Institute A/S, Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
Inventors:
JAMES TIMMONS, STEEN KNUDSEN, TUOMO RANKINEN, CARL JOHAN SUNDBERG, CLAUDE BOUCHARD
Abstract: The present disclosure provides an electrode and an feedthrough for an implantable medical device. In one embodiment, the implantable electrode and the implantable feedthrough both comprise electrically insulating diamond material and electrically conductive diamond material that form an interface. Further, the present disclosure provides method for fabricating the implantable electrode and the feedthrough.
Type:
Application
Filed:
December 3, 2013
Publication date:
April 3, 2014
Applicants:
National ICT Australia Limited, The University of Melbourne
Inventors:
Hamish Meffin, Kate Fox, David Garrett, Kumaravelu Ganesan, Steven Prawer, Samantha Lichter, Igor Aharonovich
Abstract: The present disclosure provides aromatic-cationic peptide compositions and methods of using the same. The methods comprise use of the peptides in electron transport and electrical conductance.
Type:
Application
Filed:
March 22, 2012
Publication date:
April 3, 2014
Applicants:
Stealth Peptides International, Inc., Cornell University
Inventors:
Hazel H. Szeto, Alexander V. Birk, D. Travis Wilson
Abstract: A microfibrillar high molecular weight chitosan-based textile can be used as a hemostat. The chitosan has been treated in a nitrogen field by applying energy to ionize nitrogen in and around the chitosan textile. A single or multiple such treatments may be employed. For example, the chitosan textile may be irradiated under nitrogen using ?-irradiation, treated under a nitrogen plasma, or both.
Type:
Application
Filed:
December 4, 2013
Publication date:
April 3, 2014
Applicant:
Loma Linda University Medical Center
Inventors:
Wolff M. Kirsch, Yong Hua Zhu, Samuel Hudson
Abstract: Provided herein are methods for inactivating a target polynucleotide. The methods use a psiRNA having a 5? region and a 3? region. The 5? region includes, but is not limited to, 5 to 10 nucleotides chosen from a repeat from a CRISPR locus immediately upstream of a spacer. The 3? region is substantially complementary to a portion of the target polynucleotide. The methods may be practiced in a prokaryotic microbe or in vitro. Also provided are polypeptides that have endonuclease activity in the presence of a psiRNA and a target polynucleotide, and methods for using the polypeptides.
Type:
Application
Filed:
September 12, 2013
Publication date:
April 3, 2014
Applicant:
University of Georgia Research Foundation, Inc.
Inventors:
REBECCA M. TERNS, MICHAEL P. TERNS, CARYN R. HALE
Abstract: The present invention provides reagents, methods and systems for predicting the inhibitory activity of an antibody or variant thereof comprising: determining a binding affinity of the antibody or variant thereof to a Fc activating receptor; determining a binding affinity of the antibody or variant thereof to a Fc inhibitory receptor, and calculating the ratio of said activating binding affinity to said inhibitory binding affinity (A/I ratio), wherein the magnitude of said ratio is less than one (1).
Abstract: Compactly-integrated electronic structures and associated systems and methods are provided. Certain embodiments relate to the ability to integrate nanowire-based detectors with optical components.
Type:
Application
Filed:
October 2, 2012
Publication date:
April 3, 2014
Applicants:
Massachusetts Institute of Technology, The Trustees of Columbia University in the City of New York
Inventors:
The Trustees of Columbia University in the City of New York, Massachusetts Institute of Technology
Abstract: The disclosure relates to methods and compositions for preventing or inhibiting pathogenic bacterial infections in a subject caused by pathogenic bacteria expressing a multivalent adhesion molecule (MAM) polypeptide by administering to a subject a composition comprising a MAM polypeptide or a non-pathogenic bacterium expressing a MAM polypeptide, or a combination thereof.
Type:
Application
Filed:
March 30, 2012
Publication date:
April 3, 2014
Applicant:
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Inventors:
Kim Orth, Hyeilin Ham, Anne-Marie Krachler
Abstract: The present invention provides compositions and methods for the pretreatment of lignocellulosic material. The present invention further provides for pretreated lignocellulosic material that can be used to produce products, such as fermentable sugars.
Type:
Application
Filed:
December 9, 2013
Publication date:
April 3, 2014
Applicants:
Queensland University of Technology, Syngenta Participations AG
Inventors:
Zhanying Zhang, Ian Mark O'Hara, William Orlando Sinclair Doherty
Abstract: The present invention relates to conjugates and vaccine compositions for treatment of opioid addiction, and methods of use of these conjugates and compositions.
Type:
Application
Filed:
September 17, 2013
Publication date:
April 3, 2014
Applicants:
Minneapolis Medical Research Foundation, REGENTS OF THE UNIVERSITY OF MINNESOTA
Inventors:
Paul Richard Pentel, Philip S. Portoghese, Marco Pravetoni, Morgan C.P. Le Naour
Abstract: The present invention provides methods and compositions for the stimulation of immune responses. In particular, the present invention provides immunogenic nanoemulsion compositions and methods of administering the same (e.g., via a heterologous prime/boost protocol (e.g., utilizing the same nanoemulsion in each the prime and boost administrations)) to induce immune responses (e.g., innate and/or adaptive immune responses (e.g., for generation of host immunity against an environmental pathogen)). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.
Type:
Application
Filed:
September 30, 2013
Publication date:
April 3, 2014
Applicants:
NANOBIO CORPORATION, THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Inventors:
James R. Baker, JR., Douglas Smith, Ali I. Fattom, Jakub Simon